For many people, ibuprofen, naproxen, and acetaminophen are godsends.
Whenever they feel a niggling ache or pain, they pop a pill and feel right as rain.
Elbow pain from benching? No problem.
Knee pain from squatting? Nothing a few pills can’t fix.
Shoulder pain from overhead press? Not today.
Have a bad case of DOMS? NBD, man.
Take a few pills, and you’ll be able to push through workouts that might otherwise keep you sidelined.
And others even take these over-the-counter (OTC) painkillers on a regular basis, just in case something starts to hurt.
If you’ve read anything about these drugs, though, then you may have heard that they can also interfere with muscle growth.
Some even go so far as to say that you should avoid them at all costs. It’s better to stay home and wait for your body to heal itself than to take a pill that kills your gains.
Who’s right, and what should you do?
That’s what you’re going to learn in this podcast. By the end, you’ll know how painkillers affect muscle growth, whether or not taking them will interfere with strength and muscle gain, and how to balance the pros and cons to get the best of both worlds.
Let’s get started.
Lastly, if you want to support the show, please drop a quick review of it over on iTunes. It really helps!
What did you think of this episode? Have anything else to share? Let me know in the comments below!
+ Scientific References
- Trappe, T. A., Carroll, C. C., Dickinson, J. M., LeMoine, J. K., Haus, J. M., Sullivan, B. E., Lee, J. D., Jemiolo, B., Weinheimer, E. M., & Hollon, C. J. (2011). Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults. American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 300(3), R655. https://doi.org/10.1152/ajpregu.00611.2010
- Krentz, J. R., Quest, B., Farthing, J. P., Quest, D. W., & Chilibeck, P. D. (2008). The effects of ibuprofen on muscle hypertrophy, strength, and soreness during resistance training. Applied Physiology, Nutrition, and Metabolism, 33(3), 470–475. https://doi.org/10.1139/H08-019
- Lilja, M., Mandić, M., Apró, W., Melin, M., Olsson, K., Rosenborg, S., Gustafsson, T., & Lundberg, T. R. (2018). High doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults. Acta Physiologica, 222(2), e12948. https://doi.org/10.1111/apha.12948
- Schoenfeld, B. J. (2012). The use of nonsteroidal anti-inflammatory drugs for exercise-induced muscle damage: implications for skeletal muscle development. Sports Medicine (Auckland, N.Z.), 42(12), 1017–1028. https://doi.org/10.1007/BF03262309
- Muñoz-Cánoves, P., Scheele, C., Pedersen, B. K., & Serrano, A. L. (2013). Interleukin-6 myokine signaling in skeletal muscle: A double-edged sword? In FEBS Journal (Vol. 280, Issue 17, pp. 4131–4148). Wiley-Blackwell. https://doi.org/10.1111/febs.12338
- Horsley, V., & Pavlath, G. K. (2003). Prostaglandin F2α stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. Journal of Cell Biology, 161(1), 111–118. https://doi.org/10.1083/jcb.200208085
- Dalle, S., Rossmeislova, L., & Koppo, K. (2017). The role of inflammation in age-related sarcopenia. In Frontiers in Physiology (Vol. 8, Issue DEC). Frontiers Media S.A. https://doi.org/10.3389/fphys.2017.01045
- Tezze, C., Romanello, V., Desbats, M. A., Fadini, G. P., Albiero, M., Favaro, G., Ciciliot, S., Soriano, M. E., Morbidoni, V., Cerqua, C., Loefler, S., Kern, H., Franceschi, C., Salvioli, S., Conte, M., Blaauw, B., Zampieri, S., Salviati, L., Scorrano, L., & Sandri, M. (2017). Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence. Cell Metabolism, 25(6), 1374-1389.e6. https://doi.org/10.1016/j.cmet.2017.04.021
- V, P., & J, H. (2003). Muscle injuries and repair: the role of prostaglandins and inflammation. Histology and Histopathology, 18(4), 1243–1256. https://doi.org/10.14670/HH-18.1243
- Chazaud, B., Sonnet, C., Lafuste, P., Bassez, G., Rimaniol, A. C., Poron, F., Authier, F. J., Dreyfus, P. A., & Gherardi, R. K. (2003). Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. Journal of Cell Biology, 163(5), 1133–1143. https://doi.org/10.1083/jcb.200212046
- Journal, I., & Factor, I. (2015). BioMed Research International ( J BIOMED BIOTECHNOL ). Computational and Mathematical Methods in Medicine, 2015, 2–4. https://doi.org/10.1155/2015
- Wåhlin-Larsson, B., Carnac, G., & Kadi, F. (2014). The influence of systemic inflammation on skeletal muscle in physically active elderly women. Age, 36(5), 9718. https://doi.org/10.1007/s11357-014-9718-0
- Degens, H. (2010). The role of systemic inflammation in age-related muscle weakness and wasting. Scandinavian Journal of Medicine & Science in Sports, 20(1), 28–38. https://doi.org/10.1111/j.1600-0838.2009.01018.x
- What is an inflammation? - InformedHealth.org - NCBI Bookshelf. (n.d.). Retrieved May 7, 2020, from https://www.ncbi.nlm.nih.gov/books/NBK279298/
- Cottler, L. B., Ben Abdallah, A., Cummings, S. M., Barr, J., Banks, R., & Forchheimer, R. (2011). Injury, pain, and prescription opioid use among former National Football League (NFL) players. Drug and Alcohol Dependence, 116(1–3), 188–194. https://doi.org/10.1016/j.drugalcdep.2010.12.003
- The role of nonsteroidal anti-inflammatory drugs in the treatment of acute soft tissue injuries. - PubMed - NCBI. (n.d.). Retrieved May 7, 2020, from https://www.ncbi.nlm.nih.gov/pubmed/16558472
- Ziltener, J. L., Leal, S., & Fournier, P. E. (2010). Non-steroidal anti-inflammatory drugs for athletes: An update. In Annals of Physical and Rehabilitation Medicine (Vol. 53, Issue 4, pp. 278–288). Elsevier Masson. https://doi.org/10.1016/j.rehab.2010.03.001
- Chou, R., & Huffman, L. H. (2007). Medications for acute and chronic low back pain: A review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. In Annals of Internal Medicine (Vol. 147, Issue 7, pp. 505–514). American College of Physicians. https://doi.org/10.7326/0003-4819-147-7-200710020-00008
- Mallappallil, M., Sabu, J., Friedman, E. A., & Salifu, M. (2017). What do we know about opioids and the kidney? In International Journal of Molecular Sciences (Vol. 18, Issue 1). MDPI AG. https://doi.org/10.3390/ijms18010223
- Kapusta, D. R., Jones, S. Y., & DiBona, G. F. (1991). Renal mu opioid receptor mechanisms in regulation of renal function in rats. Journal of Pharmacology and Experimental Therapeutics, 258(1), 111–117. https://www.ncbi.nlm.nih.gov/pubmed/1677034
- Terenius, L. (1976). Opioid receptors and their ligands. Acta Physiologica Scandinavica, 98(SUP440). https://doi.org/10.2174/1568026043451618
- Somasundaram, Sigthorsson, Simpson, Watts, Jacob, Tavares, Rafi, Roseth, Foster, Price, Wrigglesworth, & Bjarnason. (2000). Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Alimentary Pharmacology and Therapeutics, 14(5), 639–650. https://doi.org/10.1046/j.1365-2036.2000.00723.x
- Wolfe, L. S. (1982). Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, and Other Derivatives of Carbon‐20 Unsaturated Fatty Acids. Journal of Neurochemistry, 38(1), 1–14. https://doi.org/10.1111/j.1471-4159.1982.tb10847.x